skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

227 studies were found about ( Combivir OR lamivudine AND zidovudine )

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00004999

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00004585

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Condition: HIV Infections

NCT ID: NCT00323544

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Condition: HIV Infections

NCT ID: NCT00004981

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Condition: HIV Infections; Dyslipidemias; Glucose Metabolism Disorders; Metabolic Diseases; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00192621

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Condition: HIV Infections

NCT ID: NCT00424814

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00112047

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

Condition: HIV Infection; Pregnancy; Breastfeeding; HIV Infections

NCT ID: NCT00936195

GW873140 In Combination With Combivir In HIV Infected Subjects

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00104429

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Condition: HIV Infections

NCT ID: NCT00002179

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00005106

A Study of Two Anti-HIV Drug Combinations

Condition: HIV Infections

NCT ID: NCT00002203

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00005764

A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children

Condition: HIV Infections

NCT ID: NCT00001066

A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past

Condition: HIV Infections

NCT ID: NCT00002320

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00011895

A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002367

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Condition: HIV Infections

NCT ID: NCT00013520

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Condition: HIV Infections

NCT ID: NCT00043888

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

Condition: HIV Infection

NCT ID: NCT00082394

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00006441

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Condition: HIV Infections

NCT ID: NCT00385645

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Condition: HIV Infections

NCT ID: NCT00002409

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00043953

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

Condition: HIV

NCT ID: NCT00960622

Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa

Condition: HIV

NCT ID: NCT01088516

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

Condition: Disease Transmission, Vertical; Vertical Human Immunodeficiency Virus Transmission; HIV Infections

NCT ID: NCT00099359

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Condition: HIV

NCT ID: NCT01275625

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002217

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa

Condition: Human Immunodeficiency Virus

NCT ID: NCT02028676

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs

Condition: HIV Infections

NCT ID: NCT00002391

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Condition: HIV Infections

NCT ID: NCT00005002

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Condition: HIV-1 Infection

NCT ID: NCT01772940

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002389

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001094

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002379

A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000944

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Condition: HIV Infections

NCT ID: NCT00000903

A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000887

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001075

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Condition: HIV Infections

NCT ID: NCT00000841

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

Condition: HIV Infections

NCT ID: NCT00002155

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00002190

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

Condition: HIV Infections

NCT ID: NCT00002371

Bioequivalence Study of Pediatric Formulations to Treat HIV Infection

Condition: HIV; AIDS

NCT ID: NCT01469520

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00075231

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002400

A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002410

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000888

Zidovudine and Lamivudine Given Once Versus Twice Daily

Condition: HIV Infections

NCT ID: NCT00014014

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00006617

A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002195

PREventing Progression of Adipose Tissue Redistribution

Condition: HIV Infections

NCT ID: NCT00389194

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Condition: HIV Infections

NCT ID: NCT00014937

A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine

Condition: HIV Infections

NCT ID: NCT00013897

Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)

Condition: HIV; Tuberculosis

NCT ID: NCT00851630

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

Condition: Human Immunodeficiency Virus Type 1

NCT ID: NCT00110305

Breastfeeding, Antiretroviral, and Nutrition Study

Condition: HIV Infections

NCT ID: NCT00164736

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

Condition: HIV Infections

NCT ID: NCT00100568

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

Condition: HIV Infections

NCT ID: NCT00672412

Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)

Condition: HIV Infections

NCT ID: NCT00346567

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002369

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001084

A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002401

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001085

Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000920

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00002216

A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding

Condition: HIV Infections

NCT ID: NCT00146380

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004852

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China

Condition: HIV Infections

NCT ID: NCT00100594

FREE Study: Efficacy and Toxicity of Trizivir

Condition: HIV Infections

NCT ID: NCT00405925

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002168

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001067

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)

Condition: HIV

NCT ID: NCT01253538

Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics

Condition: HIV

NCT ID: NCT01386970

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Condition: HIV Infections

NCT ID: NCT00000838

Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

Condition: HIV Infections; Central Nervous System Diseases; Dementia

NCT ID: NCT01340950

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00141284

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

Condition: HIV-1 Infection

NCT ID: NCT01714414

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Condition: HIV Infection

NCT ID: NCT00234923

Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00004998

A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00144183

Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada

Condition: HIV-1

NCT ID: NCT00324649

Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

Condition: HIV Infections

NCT ID: NCT00256828

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Condition: HIV Infections

NCT ID: NCT00002199

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001083

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

Condition: HIV Infection

NCT ID: NCT00246610

Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis

Condition: HIV Infections; Tuberculous Meningitis

NCT ID: NCT00433719

The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

Condition: HIV Infections

NCT ID: NCT00002436

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Condition: HIV Infection

NCT ID: NCT00038506

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00966160

A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01597648

Antiretroviral Therapy for Advanced HIV Disease in South Africa

Condition: HIV

NCT ID: NCT00342355

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Condition: HIV Infections

NCT ID: NCT00001095

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Condition: HIV Infections

NCT ID: NCT00002416

NRTI-Sparing Pilot Study

Condition: HIV; Mitochondrial Toxicity

NCT ID: NCT00143689

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Condition: HIV-1 Infection

NCT ID: NCT00915655

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Condition: HIV Infections

NCT ID: NCT00002208

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Condition: HIV Infections

NCT ID: NCT00000882

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Condition: Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%

NCT ID: NCT00199979

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01137981

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Condition: HIV Infections

NCT ID: NCT00002184

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00017719

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine

Condition: HIV-1

NCT ID: NCT00098293

A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000896

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Condition: HIV Infections

NCT ID: NCT00000885

Steady State PK in Malnourished HIV Infected Children

Condition: HIV Positive; Malnourished

NCT ID: NCT01818258

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Condition: HIV-1 Infection

NCT ID: NCT01352715

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002411

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00000919

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

Condition: HIV Infections

NCT ID: NCT00028327

Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00144157

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Condition: HIV Infections

NCT ID: NCT00000916

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries

Condition: HIV Infections

NCT ID: NCT01061151

A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000878

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Condition: HIV; Hepatitis B

NCT ID: NCT01125696

Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV

Condition: HIV Transmission; HIV Infections

NCT ID: NCT00949234

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00000872

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents

Condition: Human Immuno Deficiency (HIV) Infections

NCT ID: NCT00799864

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00120510

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

Condition: HIV Infections

NCT ID: NCT00099632

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Condition: HIV Infections

NCT ID: NCT00002124

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT00002183

Increasing HAART-Induced Immune Restoration With Cyclosporine

Condition: HIV Infections

NCT ID: NCT00031070

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients

Condition: HIV; Zidovudine Adverse Reaction

NCT ID: NCT01540240

Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Condition: HIV Infections

NCT ID: NCT01618305

3TC (Lamivudine; GR109714X) Open-Label Program

Condition: HIV Infections

NCT ID: NCT00002108

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Condition: HIV Infection

NCT ID: NCT00326716

Combination of Efavirenz and Truvada - COMET Study

Condition: HIV Infections

NCT ID: NCT00224458

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00307151

Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00876733

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

Condition: HIV Infections

NCT ID: NCT00000831

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Condition: HIV Infections

NCT ID: NCT00000952

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00002378

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00001443

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Condition: HIV Infections

NCT ID: NCT00084136

A Phase I Study of Methotrexate for HIV Infection

Condition: HIV Infections

NCT ID: NCT00000834

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Condition: HIV Infections

NCT ID: NCT00000902

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

Condition: HIV Infections

NCT ID: NCT00618176

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Condition: HIV Infections

NCT ID: NCT00537966

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

Condition: Malaria; HIV Infections

NCT ID: NCT00993031

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Condition: HIV Infections; Liver Toxicity; Hepatitis Co-infection

NCT ID: NCT01273142

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00021463

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Condition: HIV Infections

NCT ID: NCT00000918

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00001119

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00000875

Study of Anti-HIV Therapy Intensification

Condition: HIV Infections

NCT ID: NCT00034086

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Condition: Fracture; Infection, Human Immunodeficiency Virus

NCT ID: NCT01077557

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Condition: HIV Infection

NCT ID: NCT00001644

Sex, Aging and Antiretroviral Pharmacokinetics

Condition: HIV Infections

NCT ID: NCT00666055

HIV Treatment and CVD Events

Condition: HIV Infection; Cardiovascular Disease; Infection, Human Immunodeficiency Virus; Acute Myocardial Infarction

NCT ID: NCT01054638

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

Condition: HIV-1 Infection

NCT ID: NCT02057796

PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00162643

The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

Condition: AIDS; HIV Infection

NCT ID: NCT00197613

Dose Reduction of Lopinavir in Children

Condition: HIV Infections

NCT ID: NCT00887120

Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers

Condition: HIV Infections

NCT ID: NCT01511237

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Condition: HIV Infections; Malaria

NCT ID: NCT00719602

MARCH Central Nervous System Substudy

Condition: HIV-1 Infection

NCT ID: NCT01637233

A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART

Condition: HIV Infections

NCT ID: NCT00000874

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Condition: HIV Infections

NCT ID: NCT00158405

Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients

Condition: HIV Infections

NCT ID: NCT00273975

ARVs to Prevent Breastmilk HIV:Viral and Immune Responses

Condition: HIV Infections

NCT ID: NCT00167674

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Condition: HIV Infections

NCT ID: NCT00002429

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002376

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

Condition: NVP Plasma Level; NVP Related Mutation; 3TC Related Mutation

NCT ID: NCT00872872

Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00005000

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Condition: HIV Infections; Hemophilia A

NCT ID: NCT00002386

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00004736

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Condition: HIV Infections

NCT ID: NCT00000865

A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive

Condition: HIV Infections

NCT ID: NCT00002215

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00078247

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Condition: HIV Infections

NCT ID: NCT00050895

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Condition: HIV Infections

NCT ID: NCT00000891

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Condition: HIV Infections

NCT ID: NCT00000870

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001087

Strategies for Delivering Anti-HIV Therapy in South Africa

Condition: HIV Infections

NCT ID: NCT00080522

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Condition: HIV Infections

NCT ID: NCT00000923

MARCH Renal Substudy

Condition: Proteinuria; HIV

NCT ID: NCT01637259

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002209

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122226

Blood Levels of Abacavir in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00087945

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00002162

A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002442

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV

Condition: Kwashiorkor; Marasmus; Severe Acute Malnutrition; HIV

NCT ID: NCT01529125

Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy

Condition: HIV

NCT ID: NCT01694017

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Condition: HIV Infection

NCT ID: NCT01576731

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Condition: HIV Infection

NCT ID: NCT01533272

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01776996

A Study of Disease Progression and Anti-HIV Treatments

Condition: HIV Infections

NCT ID: NCT00001068

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Condition: HIV Infections

NCT ID: NCT00621166

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Condition: Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic

NCT ID: NCT01908660

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01363011

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00127959

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Condition: HIV Infections

NCT ID: NCT00164762

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00050908

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001086

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition: AIDS-Related Kaposi's Sarcoma

NCT ID: NCT00834457

Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

Condition: HIV Infections

NCT ID: NCT00005018

A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Condition: HIV Infections

NCT ID: NCT00029341

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

Condition: HIV Infections

NCT ID: NCT01159223

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Condition: Healthy Volunteers

NCT ID: NCT01220232

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Condition: Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus

NCT ID: NCT01448707

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

Condition: HIV Infections

NCT ID: NCT00753324

Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses

Condition: HIV

NCT ID: NCT02002286

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders

Condition: HIV

NCT ID: NCT01817283

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733